FDA Inspection 1005874 — Bergen Community Regional Blood Center

Bergen Community Regional Blood Center — FEI 3011391250

The FDA completed an inspection of Bergen Community Regional Blood Center on March 9, 2017 in Parsippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 9, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Parsippany, NJ (United States)